STUB1 and atherosclerosis: Briefly, CHIP can diminish the strength of the interaction between monocytes and NETS, and neutralization of NET-resident H2A by CHIP shows therapeutic benefits by reducing arterial adhesion as well as decreasing atherosclerotic lesion sizes in a model of LPS-accelerated atherosclerosis [18].